A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancer
- Conditions
- anaplastic thyroid cancer
- Registration Number
- JPRN-UMIN000008574
- Lead Sponsor
- Anaplastic Thyroid Carcinoma Consortium Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Not provided
Patient who matches one of these criterion. (1) suspision for interstitial pneumonia or pulmonary fibrosis by chest radiograph (2) brain metastasis with symptom (3) presence of the active peptic ulcer (4) presence of the active other malignancies (5) fever more than 38C (6) severe complication (e.g. myocardial infarction within 3 months, heart failure with clinically problem, poorly controlled diabetes mellitus, severe infectious disease. (7) past history for severe drug allergy (8) past history of hypersisitivity to polyoxyethylated or hydrogenated castor oil (9) hypersisitivity to alcohol (10) pregnant or nursing women (11) difficult to entry due to psychological problem (12) previous chemotherapy or radiation therapy to the present illness (13) physician judged improper to entry this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method